These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29725729)

  • 21. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
    Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M
    World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of on-chip fully automated immunoassay system "μTASWako i30" to measure the changes in glycosylation profiles of alpha-fetoprotein in patients with hepatocellular carcinoma.
    Kurosawa T; Watanabe M
    Proteomics; 2016 Dec; 16(24):3056-3061. PubMed ID: 27272472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoglycosidase-mediated incorporation of 18O into glycans for relative glycan quantitation.
    Zhang W; Wang H; Tang H; Yang P
    Anal Chem; 2011 Jun; 83(12):4975-81. PubMed ID: 21591765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Xeno-glycomics database (XDB): a relational database of qualitative and quantitative pig glycome repertoire.
    Park HM; Park JH; Kim YW; Kim KJ; Jeong HJ; Jang KS; Kim BG; Kim YG
    Bioinformatics; 2013 Nov; 29(22):2950-2. PubMed ID: 24013926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automating mass spectrometry-based quantitative glycomics using aminoxy tandem mass tag reagents with SimGlycan.
    Meitei NS; Apte A; Snovida SI; Rogers JC; Saba J
    J Proteomics; 2015 Sep; 127(Pt A):211-22. PubMed ID: 26003531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Throughput Analysis of the IgG N-Glycome by UPLC-FLR.
    Pučić-Baković M
    Methods Mol Biol; 2017; 1503():21-29. PubMed ID: 27743356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A MALDI-MS-based quantitative targeted glycomics (MALDI-QTaG) for total N-glycan analysis.
    Kim KJ; Kim YW; Hwang CH; Park HG; Yang YH; Koo M; Kim YG
    Biotechnol Lett; 2015 Oct; 37(10):2019-25. PubMed ID: 26063621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisecting Lewis X in Hybrid-Type
    Helm J; Grünwald-Gruber C; Thader A; Urteil J; Führer J; Stenitzer D; Maresch D; Neumann L; Pabst M; Altmann F
    Anal Chem; 2021 Nov; 93(45):15175-15182. PubMed ID: 34723506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micro- and macroheterogeneity of N-glycosylation yields size and charge isoforms of human sex hormone binding globulin circulating in serum.
    Sumer-Bayraktar Z; Nguyen-Khuong T; Jayo R; Chen DD; Ali S; Packer NH; Thaysen-Andersen M
    Proteomics; 2012 Nov; 12(22):3315-27. PubMed ID: 23001782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
    Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
    J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards personalized diagnostics via longitudinal study of the human plasma N-glycome.
    Hennig R; Cajic S; Borowiak M; Hoffmann M; Kottler R; Reichl U; Rapp E
    Biochim Biophys Acta; 2016 Aug; 1860(8):1728-38. PubMed ID: 27038647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dynamic brain N-glycome.
    Klarić TS; Lauc G
    Glycoconj J; 2022 Jun; 39(3):443-471. PubMed ID: 35334027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation and cancer: moving glycomics to the forefront.
    Drake RR
    Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PNGase F-mediated incorporation of (18)O into glycans for relative glycan quantitation.
    Zhang W; Cao W; Huang J; Wang H; Wang J; Xie C; Yang P
    Analyst; 2015 Feb; 140(4):1082-9. PubMed ID: 25521995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing.
    Vanhooren V; Liu XE; Franceschi C; Gao CF; Libert C; Contreras R; Chen C
    Mech Ageing Dev; 2009; 130(1-2):92-7. PubMed ID: 19070631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoscience aids in biomarker discovery.
    Hua S; An HJ
    BMB Rep; 2012 Jun; 45(6):323-30. PubMed ID: 22732216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.
    Fang M; Zhao YP; Zhou FG; Lu LG; Qi P; Wang H; Zhou K; Sun SH; Chen CY; Gao CF
    Int J Cancer; 2010 Jul; 127(1):148-59. PubMed ID: 19904744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward automated glycan analysis.
    Nishimura S
    Adv Carbohydr Chem Biochem; 2011; 65():219-71. PubMed ID: 21763513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
    Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
    J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abundance-ratio-based semiquantitative analysis of site-specific N-linked glycopeptides present in the plasma of hepatocellular carcinoma patients.
    Lee HJ; Cha HJ; Lim JS; Lee SH; Song SY; Kim H; Hancock WS; Yoo JS; Paik YK
    J Proteome Res; 2014 May; 13(5):2328-38. PubMed ID: 24628331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.